New depression drug enters Mid-Stage testing
NCT ID NCT06842992
Summary
This study tested a new drug called NH102 to see if it helps reduce symptoms of major depression. It involved 243 adults with depression who took either NH102 at different doses, an existing drug (duloxetine), or a placebo for 6 weeks. The main goal was to see how well NH102 worked compared to the other options and to check its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Mental Health Center
Shanghai, China
Conditions
Explore the condition pages connected to this study.